Average Insider

Where insiders trade, we follow

$GRML
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.
Healthcare
Sector
Biotechnology
Industry
Joseph Sinkule
CEO
3
Employees
$0.23
Current Price
$17.82M
Market Cap
52W Low$0.16
Current$0.2320.6% above low, 79.4% below high
52W High$0.53

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys11$55,944.00240,000All Buys
Sells00--
1 monthBuys33$326,046.001,780,000All Buys
Sells00--
2 monthsBuys33$326,046.001,780,0008.04:1
Sells11$40,547.50175,000
3 monthsBuys33$326,046.001,780,0008.04:1
Sells11$40,547.50175,000
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Jul 22, 2026
Sawyer Jason David
Director
Purchase240,000$0.23$55,944.00View Details
Jul 20, 2026
McGarity Jon
Director
Purchase140,000$0.18$24,822.00View Details
Jul 16, 2026
LeBlanc Jeff
Chief Financial Officer
Purchase1,400,000$0.18$245,280.00View Details
Jun 25, 2026
El-Dada Riad Hussein
Director
Sale175,000$0.23$40,547.50View Details

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Version: v26.7.3